These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1215207)

  • 41. [Myasthenia syndrome after peroral treatment with penicillamine].
    Francois J; Verbraeken H; Gabriel P; Wille C
    Ophthalmologica; 1978; 177(2):88-91. PubMed ID: 745827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Penicillamine-induced myasthenia gravis.
    Sundstrom WR; Schuna AA
    Arthritis Rheum; 1979 Feb; 22(2):197-8. PubMed ID: 420710
    [No Abstract]   [Full Text] [Related]  

  • 43. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myasthenia gravis and D-penicillamine.
    Dawkins RL; Garlepp MJ; McDonald BL; Williamson J; Zilko PJ; Carrano J
    J Rheumatol Suppl; 1981; 7():169-74. PubMed ID: 7014873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Initiation of myasthentic reactions by means of d-penicillamine (author's transl1].
    Rosenberger K; Winter H; Adams AE
    Nervenarzt; 1978 May; 49(5):277-81. PubMed ID: 673084
    [No Abstract]   [Full Text] [Related]  

  • 47. [Nephrotic syndrome and inflammation of the thyroid gland after D-penicillamine].
    Haas P; Wendt H
    Wien Med Wochenschr; 1974 Jun; 124(22):333-4. PubMed ID: 4831881
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.
    Seideman P; Ayesh R
    Clin Rheumatol; 1994 Sep; 13(3):435-7. PubMed ID: 7835005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myasthenia gravis and penicillamine therapy of rheumatoid arthritis.
    Bocanegra T; Espinoza LR; Vasey FB; Germain BF
    JAMA; 1980 Oct; 244(16):1822-3. PubMed ID: 7420683
    [No Abstract]   [Full Text] [Related]  

  • 51. [Myasthenic syndrome following oral treatment with penicillamine].
    François J; Verbraeken H; Gabriel P; Wille C
    Bull Soc Belge Ophtalmol; 1978; 182():126-30. PubMed ID: 756327
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
    Meyer O
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Gordon RA; Burnside JW
    Ann Intern Med; 1977 Nov; 87(5):578-9. PubMed ID: 921089
    [No Abstract]   [Full Text] [Related]  

  • 56. Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatoid arthritis.
    Hearn J; Tiliakos NA
    South Med J; 1986 Sep; 79(9):1185-6. PubMed ID: 3750012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 58. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
    Andonopoulos AP; Terzis E; Tsibri E; Papasteriades CA; Papapetropoulos T
    Clin Rheumatol; 1994 Dec; 13(4):586-8. PubMed ID: 7697959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myasthenia gravis caused by D-penicillamine].
    Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
    Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.